Literature DB >> 6107035

Restriction of latent herpes virus infection in rabbits immunized with subviral herpes simplex virus vaccine.

J Rajcáni, L Kutinová, V Vonka.   

Abstract

The ability of an experimental herpes simplex virus type 1 (HSV) vaccine to influence the establishment of latent infection was examined. The virion-free vaccine was prepared from HSV 1-infected LEP cells by extraction with Nonidet P 40. Albino rabbits were immunized with three doses of the subviral vaccine (strain KOS) and challenged with 10(5) PFU of HSV 1 (Kupka strain) into the right scarified cornea. Non-immune controls and rabbits immunized with formalin-inactivated virion vaccine (strain KOS) were infected in a similar way. At intervals from 53 to 164 days p. i., the animals were killed and fragments of both trigeminal ganglia were kept separately in culture for 10 days. In 18 out of 22 immunized animals (81.8%), latency was established in the homolateral Gasserian ganglion. The proportion of HSV-yielding fragments, was considerably higher in ganglia from non-immune animals (42.6%) as compared to those from ganglia of rabbits immunized with the subviral vaccine (5.4%) or with the whole virion vaccine (14.6%). The immunity resulting from previous vaccination restricted about 5 times the number of ganglion cells, which become virus carriers.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6107035

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  6 in total

Review 1.  The pathogenesis of acute, latent and recurrent herpes simplex virus infections.

Authors:  R J Klein
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

2.  Immunogenicity of a subviral herpes simplex type 1 preparation: reduction of recurrent disease in mice.

Authors:  V Slichtová; L Kutinová; V Vonka
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

3.  Animal studies on the efficacy of vaccination against recurrent herpes.

Authors:  M Scriba
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

4.  Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice.

Authors:  R J Klein; E Buimovici-Klein; H Moser; R Moucha; J Hilfenhaus
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

Review 5.  Developments in herpes simplex virus vaccines: old problems and new challenges.

Authors:  J Rajcáni; V Durmanová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.629

Review 6.  Combinatorial Herpes Simplex Vaccine Strategies: From Bedside to Bench and Back.

Authors:  Aziz A Chentoufi; Nisha R Dhanushkodi; Ruchi Srivastava; Swayam Prakash; Pierre-Gregoire A Coulon; Latifa Zayou; Hawa Vahed; Hiba A Chentoufi; Kathy K Hormi-Carver; Lbachir BenMohamed
Journal:  Front Immunol       Date:  2022-04-25       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.